Published in BMC Infect Dis on November 21, 2002
In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission. Antimicrob Agents Chemother (2004) 2.27
Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob Agents Chemother (2008) 1.68
Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol (2004) 1.58
Candidate polyanion microbicides inhibit HIV-1 infection and dissemination pathways in human cervical explants. Retrovirology (2006) 1.58
HIV topical microbicides: steer the ship or run aground. Am J Public Health (2004) 1.50
HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS (2009) 1.49
Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC Infect Dis (2006) 1.42
Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virol J (2008) 1.34
Combination of candidate microbicides cellulose acetate 1,2-benzenedicarboxylate and UC781 has synergistic and complementary effects against human immunodeficiency virus type 1 infection. Antimicrob Agents Chemother (2005) 1.19
Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation. Antimicrob Agents Chemother (2005) 1.13
Water dispersible microbicidal cellulose acetate phthalate film. BMC Infect Dis (2003) 1.04
Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo. Antimicrob Agents Chemother (2006) 1.02
Polyanionic microbicides modify Toll-like receptor-mediated cervicovaginal immune responses. Antimicrob Agents Chemother (2009) 1.02
A bivalent recombinant protein inactivates HIV-1 by targeting the gp41 prehairpin fusion intermediate induced by CD4 D1D2 domains. Retrovirology (2012) 1.01
Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation. Antimicrob Agents Chemother (2006) 1.00
The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket. J Med Chem (2009) 0.98
3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1. Antimicrob Agents Chemother (2010) 0.91
Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1. Antiviral Res (2011) 0.91
Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS One (2012) 0.89
Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. BMC Infect Dis (2004) 0.87
Formulating a sulfonated antiviral dendrimer in a vaginal microbicidal gel having dual mechanisms of action. Drug Dev Ind Pharm (2009) 0.85
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study. Contraception (2004) 0.85
Amphipathic properties of HIV-1 gp41 fusion inhibitors. Curr Top Med Chem (2011) 0.84
Toll-like receptors and cytokines as surrogate biomarkers for evaluating vaginal immune response following microbicide administration. Mediators Inflamm (2008) 0.83
A molecular tweezer antagonizes seminal amyloids and HIV infection. Elife (2015) 0.83
Critical design features of phenyl carboxylate-containing polymer microbicides. Antimicrob Agents Chemother (2006) 0.82
Enzymatic triggered release of an HIV-1 entry inhibitor from prostate specific antigen degradable microparticles. Int J Pharm (2011) 0.82
Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction. PLoS One (2014) 0.80
A perspective on progress and gaps in HIV prevention science. AIDS Res Hum Retroviruses (2012) 0.79
Microbicidas Metodo de Prevencion en VIH/SIDA Controlado por Mujeres. Hisp Health Care Int (2009) 0.75
A review of polymers as multifunctional excipients in drug dosage form technology. Saudi Pharm J (2015) 0.75
Feasibility of Repurposing the Polyanionic Microbicide, PPCM, for Prophylaxis against HIV Transmission during ART. ISRN Obstet Gynecol (2010) 0.75
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
A new classification for HIV-1. Nature (1998) 5.30
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol (2000) 3.68
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1988) 2.82
Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus. Antimicrob Agents Chemother (1988) 2.44
A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein. J Virol (1998) 2.12
Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities. Antimicrob Agents Chemother (1996) 1.86
Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med (2000) 1.80
A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex Transm Infect (2000) 1.74
Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis (2001) 1.72
Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr (2001) 1.63
Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis (2001) 1.57
Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm Infect (2000) 1.54
Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol (1998) 1.52
Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study. Contraception (2001) 1.50
'Chemical condoms' for the prevention of HIV infection: evaluation of novel agents against SHIV(89.6PD) in vitro and in vivo. AIDS (2001) 1.48
Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro. AIDS Res Hum Retroviruses (1992) 1.45
Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex Transm Dis (2001) 1.43
Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicrob Agents Chemother (2001) 1.39
Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicol Environ Saf (2000) 1.38
A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody. J Virol Methods (1999) 1.37
Design of a "microbicide" for prevention of sexually transmitted diseases using "inactive" pharmaceutical excipients. Biologicals (1999) 1.30
Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J Infect Dis (1998) 1.27
Intermittent shedding of human immunodeficiency virus in semen: implications for sexual transmission. J Urol (1995) 1.27
The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro. Int J STD AIDS (1995) 1.22
Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120. BMC Infect Dis (2001) 1.21
Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles. BMC Infect Dis (2002) 1.20
Extracellular HIV-1 tat protein up-regulates the expression of surface CXC-chemokine receptor 4 in resting CD4+ T cells. J Immunol (1999) 1.16
Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys. Antimicrob Agents Chemother (2000) 1.12
The rate at which human sperm are immobilized and killed by mild acidity. Fertil Steril (2000) 1.10
Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection. J Leukoc Biol (1994) 1.09
Cellulose acetate phthalate (CAP): an 'inactive' pharmaceutical excipient with antiviral activity in the mouse model of genital herpesvirus infection. Antivir Chem Chemother (1999) 1.07
Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J Acquir Immune Defic Syndr (1990) 1.07
Vaginal flora in health and disease. Clin Obstet Gynecol (1993) 1.07
Activity of dextran sulfate and other polyanionic polysaccharides against human immunodeficiency virus. J Infect Dis (1988) 1.07
AIDS models: microbicides could learn from vaccines. Nat Med (2002) 1.06
In vitro activity of a cellulose acetate phthalate topical cream against organisms associated with bacterial vaginosis. J Antimicrob Chemother (2000) 1.05
Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases. J Androl (2001) 1.04
Cellulose sulfate: tolerance and acceptability of penile application. Contraception (2001) 1.01
Anti-HIV type 1 activity of sulfated derivatives of dextrin against primary viral isolates of HIV type 1 in lymphocytes and monocyte-derived macrophages. AIDS Res Hum Retroviruses (1997) 0.94
Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity. Int J Biol Macromol (1997) 0.92
Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells. Br J Pharmacol (1994) 0.91
Role of spermine in the cytotoxic effects of seminal plasma. Am J Reprod Immunol Microbiol (1987) 0.90
Human immunodeficiency virus load. Quantitative assessment in semen from seropositive individuals and in spiked seminal plasma. J Reprod Med (1995) 0.89
A placebo-controlled, double-blind prospective study in healthy female volunteers of dextrin sulphate gel: a novel potential intravaginal virucide. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.88
Microbicide for prevention of sexually transmitted diseases using a pharmaceutical excipient. AIDS Patient Care STDS (2000) 0.87
Microflora changes with the use of a vaginal microbicide. Sex Transm Dis (2002) 0.86
Anticoagulant activity of dextran derivatives. J Biomed Mater Res (1998) 0.85
The effect of hydrophobic character of drugs and helix-coil transition of kappa-carrageenan on the polyelectrolyte-drug interaction. Pharm Res (1996) 0.82
Coulombic and noncoulombic effect of polyanions on cytochrome c structure. Biopolymers (1998) 0.80
Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins. AIDS Res Hum Retroviruses (1993) 0.80
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Virology (2005) 2.03
Role of seminal plasma in the anti-HIV-1 activity of candidate microbicides. BMC Infect Dis (2006) 1.42
Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles. BMC Infect Dis (2002) 1.20
Water dispersible microbicidal cellulose acetate phthalate film. BMC Infect Dis (2003) 1.04
Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. BMC Infect Dis (2004) 0.87
Punica granatum (pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide. Ann N Y Acad Sci (2005) 0.79
Anti-HIV-1 activity of poly(mandelic acid) derivatives. Biomacromolecules (2007) 0.79
Development of a gel permeation chromatographic assay to achieve mass balance in cellulose acetate phthalate stability studies. J Pharm Biomed Anal (2008) 0.75